Skip to main content

Table 1 Pre-operative patient characteristics comparing cAVR and su-AVR groups

From: Sutureless Biological Aortic Valve Replacement (Su-AVR) in Redo operations: a retrospective real-world experience report of clinical and echocardiographic outcomes

 

Conventional AVR (cAVR) (Perimount) (n = 52)

Sutureless AVR (su-AVR) (Perceval) (n = 27)

P value

Demographics

 Age

57.6 ± 2.5

59.6 ± 2.4

0.607*

 Male

69.2 (36)

59.2 (16)

0.379

 BMI

26.6 ± 0.7

28.7 ± 1.0

0.081*

Cardiac-Comorbidities

 Hypertension

55.8 (29)

66.7 (18)

0.352

 PAD

3.8(2)

7.4 (2)

0.496

 Infective Endocarditis

17.3 (9)

29.6 (8)

0.252

NYHA(median)

3

2

0.036

 More than 1 sternotomy

7.7 (4)

22.2 (6)

0.250

Other-Comorbidities

 Diabetes Oral

5.8 (3)

14.8 (4)

0.542

 Diabetes Insulin

3.8 (2)

0.0 (0)

0.542

 Smoking

42.3 (22)

48.1 (13)

0.555

 COPD

9.6 (5)

22.2 (6)

0.127

 History of stroke

5.8 (3)

7.4 (2)

0.816

 CKD

3.8 (2)

7.4 (2)

0.514

Echocardiography Findings

Left Ventricular Functions

  

0.394

 EF good

88.5 (46)

81.4 (22)

 

 EF moderate

9.6 (5)

14.8 (4)

 

 EF poor

1.9 (1)

3.8 (1)

 

 EF%

57.5 ± 1.3

58.2 ± 2.0

0.742

Valvular Functions

  

0.527

 Aortic Stenosis

23.1 (12)

33.3 (9)

 

 Aortic Regurgitation

59.6 (31)

44.4 (12)

 

 Aortic Mixed Pathology

11.5 (6)

18.3 (5)

 

Reason for Reoperation

  

0.067

 Prosthetic Failure

36.5 (19)

48.1 (13)

 

 Infection

15.4 (8)

29.6 (8)

 

 Thrombosis

7.7 (4)

14.8 (4)

 

 Paravalvular leak

0.0 (0)

3.8 (1)

 

 Native valve degradation

3.8 (2)

3.8 (1)

 

 Regurgitation

19.2 (10)

0.0 (0)